Rep. Marshall Applauds Move to Increase Transparency in Healthcare

WASHINGTON, Nov. 3 -- Rep. Roger Marshall, R-Kansas, issued the following news release:

The Administration recently finalized a rule ensuring greater price transparency on medical services and prescription drugs that will enable Americans to make better informed decisions about their health care. Under the order, health insurance companies will be requires to disclose what they pay for their covered services and prescription drugs, and providers will also have to disclose the estimated cost of office visits and procedures.

"Greater price transparency is one of the three pillars of healthcare reform that I have long advocated for," said U.S. Congressman Roger Marshall, M.D. "We must empower patients and make Americans consumers again and we can do this by providing them with comprehensive information on the true out-of-pocket cost of a procedure or service. Transparency will drive competition among providers, which will help continue to lower the cost of health care in America."

This Executive Order builds on the Administration's commitment to bringing greater transparency to the health care industry, as part of the Administration's push to reduce the cost of healthcare and delivery greater transparency to the industry. The new Executive Order also directed the expansion of health savings accounts and other tax-preferred health accounts.

To learn more on the new Executive Order, click here: https://www.hhs.gov/about/news/2020/10/29/trump-administration-finalizes-rule-requiring-health-insurers-disclose-price-and-cost-sharing.html%5d.